SRTS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.3M
-32.5%
3.4M
-31.3%
4.9M
-28.3%
6.9M
-5.9%
7.3M
Cost of Revenue
1.5M
-36.7%
2.4M
-21.0%
3.0M
-27.1%
4.2M
-5.5%
4.4M
Gross Profit
769.0K
-22.4%
991.0K
-47.8%
1.9M
-30.1%
2.7M
-6.5%
2.9M
Operating Expenses
3.9M
-26.2%
5.3M
+6.0%
5.0M
-4.5%
5.3M
+9.0%
4.8M
R&D
1.1M
-30.3%
1.6M
-15.5%
1.9M
+3.5%
1.8M
+23.7%
1.5M
SG&A
2.8M
-24.4%
3.8M
+18.8%
3.2M
-8.7%
3.5M
+2.6%
3.4M
Operating Income
-3180000
+27.0%
-4358000
-38.4%
-3148000
-22.5%
-2569000
-32.2%
-1943000
EBITDA
-3094000
+27.4%
-4262000
-40.0%
-3045000
-23.2%
-2471000
-34.0%
-1844000
Net Income
-8749000
-233.2%
-2626000
+17.1%
-3167000
-235.8%
-943000
+9.1%
-1037000
EPS (Basic)
$-0.53
-231.3%
$-0.16
+15.8%
$-0.19
-216.7%
$-0.06
+0.0%
$-0.06
EPS (Diluted)
$-0.53
-231.3%
$-0.16
+15.8%
$-0.19
-216.7%
$-0.06
+0.0%
$-0.06
Shares (Diluted)
16.5M
-0.0%
16.5M
+0.8%
16.3M
+0.0%
16.3M
+0.0%
16.3M
Sensus Healthcare (SRTS) โ€” Financials